NEWS ARCHIVE
YEAR 2006
17 new SpineCor treatment centres opened in 5 countries during 2006!
SpineCor treatment is available in 17 new treatment centres in Australia, Canada, Poland, Spain and USA from year 2006.
SpineCor System presented around the world
Medical Education (CME) programs to inform scoliosis treatment professionals given in Germany, Poland, Spain or USA.
Spinecor System presented in numerous meetings and conferences around the world in 2006.
SpineCor presentations have been made at:
- GES Meeting, Paris, France
- AAOS Annual Meeting, Chicago, USA
- SOSORT Meeting, Poznan, Poland
- SPORC Meeting, Montreal, Canada
- 13th IMAST Meeting, Athens, Greece
- AOPA National Assembly, Florida, USA
- AAOP Annual Meeting, New Jersey, USA
YEAR 2005
1st European SpineCor Study Group Consensus Meeting – Alicante, September 19 – 20, 2005
The 1st Consensus Meeting of the European SpineCor Study Group was held in Alicante (Spain) on September 19 – 20, 2005.
The meeting joined scoliosis treatment professionals from Europe, Asia and North America, being a great opportunity to exchange experiences and discuss results, questions and problems.
The success of the meeting and the conclusions derived from experiences exchange demonstrated to be very important to improve the treatment of idiopathic scoliosis patients.
Click here to download the picture of the meeting.
YEAR 2004
New SpineCor centres opening
The Spinecor System treatment has been introduced for the first time in Greece and Poland.
SpineCor training program organized for first time for American chiropractors in New York.
YEAR 2003
So far this year the UK, USA, Greece, Israel and Spain have all opened new treatment centres to offer SpineCor treatment. Hungary plans to open 3 new treatment centres this summer following reimbursement approval.
Dr Charles Hilaire Rivard
will present the latest SpineCor treatment results at this year's Congress in
Budapest.
Promobil, the exclusive distributor for SpineCor products in Hungary, will
exhibit at the Interbor Congress. Representatives from The SpineCorporation as
well as Dr Rivard and Dr Coillard will be available during the Congress to
discuss all aspects of SpineCor treatment.
YEAR 2002
Orthopedics Today published an article on the latest treatment results presented by Dr Charles Rivard at the Congress.
Cobb
angles worsened in 52% of unbraced and 5% of brace patients studies.
Interim Results of the first prospective randomized study of scoliosis patients
with Cobb angles between 15º and 30º showed that the use of a dynamic back brace
helped prevent worsening of their curves.
Despite unquestionable success with the treatment - only a few of the braced
patients worsened - the study may soon be discontinued due to ethical concerns,
investigators said.
"This interim evaluation represents a strong tendency, where 42% of the control
group worsened compared to the treatment group, which showed a worsening in only
5% of patients. These interim results, which show a large difference in
worsening between treated and untreated patients, questions the logic of
continuing this prospective randomized study." said Charles H Rivard, MD
of Ste Justine Hospital in Montreal.
Rivard presented results during the 4th Annual Meeting of the Spine Society of
Europe, here.
If scoliosis patients with Cobb angles of this size are not treated, the curves
have a 68% risk of progression, according to the literature, he said. The
dynamic brace Rivard used resulted in aesthetic outcome and patient compliance
that was better than achieved with rigid braces. "The most important thing is
to initial treatment prior to the development of bone structure deformation," he
said.
Investigators randomized 65 children with scoliosis into two groups. For
inclusion, patients had to have scoliosis curves with initial Cobb angles
between 15 and 30º and no contraindications based on a clinical examination and
AP and lateral radiographs. The Risser sign also had to be 0, 1 or 2 and there
had to be a high risk of progression - a Cobb angle increase of 5º or more in
the past six months.
The control group consisted of 36 patients whose mean Cobb angles were 22º, + or
- 5º. The average age of all patients was 12 years.
Patient in the treated group received treatment with the SpineCor Brace (The
SpineCorporation Ltd: Chesterfield, England). The brace, available worldwide
since 1999, is adjustable and provides correction as the child moves and grows.
It consists of a plastic pelvic base, cotton vest, thigh bands and four
adjustable bands. Users wear the brace as much as 20 hours per day.
During the
study, three patients withdrew from each group. For the 33 patients left in the
control group, the mean Cobb angle at the last examination was 26º + or - 8º,
which meant that 36% of control patients were stable, 12% were improved and 42%
worsened. Worsening meant an increase in Cobb angle of >5º within six months,
which investigators confirmed using radiographs.
For the 20 patients who remained in the treated group, the mean Cobb angle while
braced was 15º + or - 7º. This resulted in improvements in 76% of treated
patients, stability in 14% curve worsening in 5%. The other six treated
patients were weaned off the brace Rivard said.
In a corresponding poster session, the investigators reported the outcomes of
the initial cohort of 195 scoliosis patients treated with the SpineCor brace.
Braced patients had an initial decrease in spine curve. Stabilization and
correction lasted to the end of treatment and was maintained for one to four
years of follow-up.
Rivard, CH, Coillard C, Zabjek KF. A prospective randomized study of the natural history of idiopathic scoliosis vs. treatment with the SpineCor brace. Interim results #35. Presented at the 4th Annual Meeting of the Spine Society of Europe, Sept 11-14, 2002, Nantes, France.
